Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Intangibles: 2017-2024

Historic Intangibles for Ptc Therapeutics (PTCT) over the last 8 years, with Dec 2024 value amounting to $118.8 million.

  • Ptc Therapeutics' Intangibles rose 20.01% to $396.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $396.5 million, marking a year-over-year increase of 20.01%. This contributed to the annual value of $118.8 million for FY2024, which is 68.70% down from last year.
  • According to the latest figures from FY2024, Ptc Therapeutics' Intangibles is $118.8 million, which was down 68.70% from $379.5 million recorded in FY2023.
  • In the past 5 years, Ptc Therapeutics' Intangibles ranged from a high of $724.8 million in FY2021 and a low of $118.8 million during FY2024.
  • In the last 3 years, Ptc Therapeutics' Intangibles had a median value of $379.5 million in 2023 and averaged $401.4 million.
  • Its Intangibles has fluctuated over the past 5 years, first increased by 1.33% in 2021, then slumped by 68.70% in 2024.
  • Over the past 5 years, Ptc Therapeutics' Intangibles (Yearly) stood at $715.3 million in 2020, then climbed by 1.33% to $724.8 million in 2021, then declined by 2.61% to $705.9 million in 2022, then tumbled by 46.24% to $379.5 million in 2023, then slumped by 68.70% to $118.8 million in 2024.